Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001554907-12-000001
Filing Date
2012-07-27
Accepted
2012-07-27 13:56:13
Documents
1
Effectiveness Date
2012-07-27
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5738
  Complete submission text file 0001554907-12-000001.txt   6791
Mailing Address 9980 SOUTH 300 WEST SUITE # 200 SALT LAKE CITY UT 84070
Business Address 9980 SOUTH 300 WEST SUITE # 200 SALT LAKE CITY UT 84070 801-285-7570
Tolero Pharmaceuticals, Inc. (Filer) CIK: 0001554907 (see all company filings)

EIN.: 452693385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-181891 | Film No.: 12989945